Cargando…
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
Background: Detection rates of early-stage lung cancer are traditionally low, which contributes to inconsistent treatment responses and high rates of annual cancer deaths. Currently, low-dose computed tomography (LDCT) screening produces a high false discovery rate. This limitation has prompted rese...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858079/ https://www.ncbi.nlm.nih.gov/pubmed/35198099 http://dx.doi.org/10.18632/oncotarget.28202 |